Solventum Corp. (SOLV) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.
Total Assets Chart for Solventum Corp.
Solventum Corp. (SOLV) total assets for FY2025 were USD 14.3B, a -1.1% change from FY2024. Solventum Corp.'s total assets grew from USD 14.1B in 2021 to USD 14.3B in 2025 (1.6% over 4 years).
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $14.12B
- Implied Share Price
- $82.96
- Enterprise Value
- $19.52B
- Revenue (TTM)
- $8.26B
- EBITDA
- $1.12B
- Profit Margin
- 17.33%
- Trailing P/E
- 10.70
- Forward P/E
- 13.04
- Price/Book (MRQ)
- 2.98
- Price/Sales (TTM)
- 1.71
- EV/EBITDA
- 7.84
- EV/Revenue
- 2.36
- Dividend Yield
- —
- Book Value
- $28.64
- Free Cash Flow (FY2025)
- -$10.00M
- Free Cash Flow Yield
- -0.07%
Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.